The abstract is read at the publisher; the summary is JClub's.
Adjunctive intra-arterial tenecteplase after EVT in cardioembolic acute ischemic stroke patients achieving near-complete to complete reperfusion increased 90-day freedom from disability (aOR 1.80; p=0.04).
- Why it matters: It addresses whether adding intra-arterial tenecteplase improves outcomes after successful reperfusion, and whether effects differ by stroke etiology (cardioembolism versus non-cardioembolism).
- What they did: In a prespecified secondary analysis of the POST-TNK randomized open-label trial, 540 patients were stratified into cardioembolism (n=272) and non-cardioembolism (n=268) subgroups; the primary endpoint was modified Rankin Scale 0–1 at 90 days.
- The result: In the cardioembolism subgroup, intra-arterial tenecteplase raised odds of disability freedom at 90 days (aOR 1.80; 95% CI 1.02–3.16; p=0.04; IPTW aOR 1.58; p=0.01) without significant differences in 90-day mortality, symptomatic intracranial hemorrhage, or any intracranial hemorrhage within 48 hours; no functional benefit was seen in the non-cardioembolism subgroup.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.